Black Rock Inc. Opiant Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$9.38 - $20.29 $4,661 - $10,084	-497 Reduced 1.24%	39,425 $799,000
Q3 2022 Nov 14, 2022	BUY	$9.52 - $13.48 $1,209 - $1,711	127 Added 0.32%	39,922 $429,000
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $45,256 - $104,287	4,472 Added 12.66%	39,795 $477,000
Q1 2022 May 12, 2022	BUY	$19.54 - $33.59 $11,313 - $19,448	579 Added 1.67%	35,323 $756,000
Q4 2021 Feb 10, 2022	BUY	$22.51 - $36.79 $226,405 - $370,033	10,058 Added 40.74%	34,744 $1.17 Million
Q3 2021 Nov 09, 2021	BUY	$13.28 - $25.79 $169,638 - $329,441	12,774 Added 107.24%	24,686 $635,000
Q2 2021 Aug 11, 2021	BUY	$10.5 - $14.19 $125,076 - $169,031	11,912 New	11,912 $160,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.